Search results
Results from the WOW.Com Content Network
Shares of Teva Pharmaceutical Industries (NYSE: TEVA) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p.m. ET. The leg down comes as the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq ...
On Tuesday, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis (UC) and Crohn ...
The stock of Teva Pharmaceutical Industries (NYSE:TEVA, 30-year Financials) is believed to be modestly undervalued, according to GuruFocus Value calculation.
Teva Pharmaceutical Industries took its present form through the efforts of Günther Friedländer and his aunt Else Kober on May 1, 1935. The original registration was under the name Teva Middle East Pharmaceutical & Chemical Works Co. Ltd. in Jerusalem, then part of Mandatory Palestine. Friedländer was a German pharmacist, botanist and ...
Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.62 in the latest trading session, marking a -1.03% move from the prior day.
The stock of Teva Pharmaceutical Industries (NYSE:TEVA, 30-year Financials) appears to be modestly undervalued, according to GuruFocus Value calculation.
In this article you are going to find out whether hedge funds think Teva Pharmaceutical Industries Limited (NYSE:TEVA) is a good investment right now. We like to check what the smart money thinks ...
While Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE:TEVA) faded from last Wednesday highs, shares ultimately climbed about 3% that day. No, it wasn’t earnings or a new drug that gave TEVA ...